SEARCH BY
Pluri is a biotechnology company that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes global well-being and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, enables the development of novel cell-based solutions to address challenges from medicine and climate change to food scarcity and animal welfare. It operates in the regenerative medicine, foodtech, and agtech sectors and provides Contract Development and Manufacturing Organization services. Pluri is based in Haifa, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Israel M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |